Literature DB >> 1019590

Studies on healing of Debrisan-treated wounds.

S Jacobsson, L Jonsson, F Rank, U Rothman.   

Abstract

Debrisan (Pharmacia AB, Sweden) is a highly hydrophilic dextran polymer in the form of dry, spheric beads. When dry Debrisan beads are placed on a wound, the wound secretions are sucked up into and between the beads. No crust is formed on the wound. Bacteria granular substances are removed with the secretions. Treatment with Debrisan was found to be very effective in cleansing discharging wounds. Since Debrisan treatment removes substances from the wound area, e.g. prostaglandins, this might affect the process of repair. The morphology of wounds was studied with the aid of histological and histochemical methods. In 15 patients, donor sites on one thigh, treated with Debrisan, were compared with donor sites on the contralateral thigh, subjected to open treatment. In pigs, comparison was made between Debrisan-treated with Vaseline-gauze-covered dermal burns. In man, the inflammatory reaction was less pronounced in the Debrisan-treated wound and located more superficially then in the wound left open, where perivascular inflammatory cell infiltrates were found even deep in the dermis. In pigs the burns exhibited similar differences. Thus the inflammatory reaction in the Debrisan-treated wounds was less pronounced than in the control wounds. Debrisan beads were never seen below the wound surface. No unfavourable influence of Debrisan treatment was observed on the process of repair.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1019590     DOI: 10.3109/02844317609105196

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg        ISSN: 0036-5556


  7 in total

1.  An enhanced Lactobacillus reuteri biofilm formulation that increases protection against experimental necrotizing enterocolitis.

Authors:  Jacob K Olson; Jason B Navarro; Jacob M Allen; Christopher J McCulloh; Lauren Mashburn-Warren; Yijie Wang; Vanessa A Varaljay; Michael T Bailey; Steven D Goodman; Gail E Besner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-31       Impact factor: 4.052

2.  uPAR and cathepsin B downregulation induces apoptosis by targeting calcineurin A to BAD via Bcl-2 in glioma.

Authors:  Rama Rao Malla; Sreelatha Gopinath; Christopher S Gondi; Kiranmai Alapati; Dzung H Dinh; Andrew J Tsung; Jasti S Rao
Journal:  J Neurooncol       Date:  2011-10-02       Impact factor: 4.130

3.  Pinch skin grafting or porcine dermis in venous ulcers: a randomised clinical trial.

Authors:  K R Poskitt; A H James; E R Lloyd-Davies; J Walton; C McCollum
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-14

Review 4.  Dextranomer: a review of its general properties and therapeutic efficacy.

Authors:  R C Heel; P Morton; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-08       Impact factor: 9.546

Review 5.  Optimal treatment of venous (stasis) ulcers in elderly patients.

Authors:  C Hansson
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

6.  Enhanced Probiotic Potential of Lactobacillus reuteri When Delivered as a Biofilm on Dextranomer Microspheres That Contain Beneficial Cargo.

Authors:  Jason B Navarro; Lauren Mashburn-Warren; Lauren O Bakaletz; Michael T Bailey; Steven D Goodman
Journal:  Front Microbiol       Date:  2017-03-27       Impact factor: 5.640

Review 7.  Lactobacillus reuteri in Its Biofilm State Improves Protection from Experimental Necrotizing Enterocolitis.

Authors:  Ameer Al-Hadidi; Jason Navarro; Steven D Goodman; Michael T Bailey; Gail E Besner
Journal:  Nutrients       Date:  2021-03-12       Impact factor: 6.706

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.